Cover Image
市場調查報告書

新興國家(巴西,俄羅斯,印度,中國,南非,韓國的)末梢血管設備市場

Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

出版商 Axis Research Mind 商品編碼 307195
出版日期 內容資訊 英文 536 Pages; 133 Tables/Charts
商品交期: 最快1-2個工作天內
價格
Back to Top
新興國家(巴西,俄羅斯,印度,中國,南非,韓國的)末梢血管設備市場 Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018
出版日期: 2014年06月30日 內容資訊: 英文 536 Pages; 133 Tables/Charts
簡介

新興市場(巴西、俄羅斯、印度、中國、南非、韓國)的末梢血管設備市場預測到2016年前將達到7億3,200萬美元。中國約佔全球市場的34%,印度以25%次之。各產品方面,末梢血管支架市場預測在2015年前將佔36%左右的佔有率,但發展最快的是血管閉合設備,預測2012∼2018年的CAGR(年複合成長率)將為14.7%%。

本報告提供上述新興市場中末梢血管設備市場的相關調查,彙整市場最新趨勢與今後預測,加入此市場的主要企業簡介與策略性活動等。

第1章 報告的焦點

  • 簡介
  • 心血管設備
  • 末梢血管設備
    • 末梢血管支架
    • 血管閉合設備
    • AAA血管支架
    • 下腔靜脈濾器
    • 旋切術設備
    • 慢性全阻塞設備
    • 血栓消除設備
    • 栓塞保護裝置
  • 末梢血管設備:市場概要
    • 中國
    • 印度
    • 巴西
    • 俄羅斯
    • 韓國
    • 南非

第2章 市場分析

  • 末梢血管設備:產業概要
  • 末梢血管設備:市場區隔
  • 末梢血管設備:全球
  • 末梢血管設備:BRICSS各國
  • 末梢血管設備:各類型
    • 末梢血管支架
    • 血管閉合設備
    • AAA血管支架
    • 下腔靜脈濾器
    • 末梢血管導管導引線
    • 旋切術設備
    • 慢性全阻塞設備
    • 血栓消除設備
    • 栓塞保護裝置
  • 成長率分析
  • 投資的焦點

第3章 產業概要

  • 心臟各醫療設備檢討
    • 心律管理設備
    • 心臟整流去顫器
    • 心律調節器
    • 心臟再同步化治療
    • 心臟監測·診斷設備
    • 介入性心臟設備
    • 心導管
    • 電生理學導管
    • EP MAPPING
    • 心房纖維顫動
    • 血管內超音波
    • 末梢血管設備
    • 末梢血管導管導引線
    • 人工心臟瓣膜
  • 心臟設備:死亡率風險與年齡
  • 心臟疾病:經濟預測
  • 非洲等方面的感染和心血管疾病
  • 心血管設備近幾年的FDA措施與認證
  • 市場趨勢
  • 主要企業簡介

第4章 產業參與企業資料庫

第5章 附錄

圖表

目錄
Product Code: ARMMR123N.1

“Getting the Most from Our Research Analysis”

BRICSS Peripheral Vascular Devices sector forecasts to reach at US$732 million by 2016. China accounts for highest percentage approximately 34% (2015) and India follows next with nearly 25% (2018) of the market share.

BRICSS projections for Peripheral Vascular Stents market share indicate nearly 36% by 2015 leaving the rest of the market to the Vascular Closure Devices, AAA Stent Grafts, Inferior Vena Cava (IVC) Filters)...etc. Vascular Closure Devices market shows that the highest Compounded Annual Growth Rate (CAGR) of 14.7% during the analysis period 2012-2018.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

BRICSS PERIPHERAL VASCULAR DEVICES - MARKET SHARE
BY GEOGRAPHY & BY TYPE - 2015-%

SEGMENTATION - By TYPE

  • PERIPHERAL VASCULAR STENTS
    • a. BALLOON-EXPANDABLE (BE)/COVERED STENT
    • b. SELF-EXPANDING (SE) STENTS
  • VASCULAR CLOSURE DEVICES
    • a. ACTIVE/ARTERIAL CLOSURE DEVICES
    • b. PASSIVE CLOSURE DEVICES
  • AAA STENT GRAFTS
  • INFERIOR VENA CAVA (IVC) FILTERS
    • a. RETRIEVABLE FILTERS
    • b. PERMANENT IVC FILTERS
  • PERIPHERAL GUIDEWIRES
  • ATHERECTOMY DEVICES
    • a. ORBITAL
    • b. ROTATIONAL
    • c. LASER
    • d. DIRECTIONAL
  • CHRONIC TOTAL OCCLUSION (CTO) DEVICES
  • THROMBECTOMY DEVICES
    • a. PERCUTANEOUS ASPIRATION THROMBECTOMY
    • b. PULLBACK THROMBECTOMY AND TRAPPING
    • c. RECIRCULATION MECHANICAL THROMBECTOMY
    • d. DIRECT CONTACT MECHANICAL FRAGMENTATION &
    • e. ULTRASOUND
  • EMBOLIC PROTECTION DEVICES (EPD)
    • a. CAROTID ARTERY STENTING
    • b. TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)

REPORT FOCUS

“Learn High Potential Market Dynamics for Strategic Business Planning”

The report ‘Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018' reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations.

The report focuses on the current market trends, estimates and forecasts for the period 2012-2018. More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 133 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

KEY COMPANIES PROFILED

ABBOTT VASCULAR DEVICES, ACCELLENT, INC., AEROTEL MEDICAL SYSTEMS, LTD., ANGIODYNAMICS, INC., ASAHI INTECC CO., LTD., ASAHI KASEI CORPORATION, BERLIN HEART GMBH, BIOHEART, INC., BIOSENSORS INTERNATIONAL GROUP, LTD., BIOTRONIK GMBH & CO. KG., BOSTON SCIENTIFIC CORPORATION, C. R. BARD, INC., CAMBRIDGE HEART, INC., CARDIOCOMM SOLUTIONS, INC., CARDIOROBOTICS, INC., COOK GROUP INCORPORATED, DRÄGER MEDICAL AG & CO. KG, ESAOTE S.P.A, FUDAN UNIVERSITY ZHONGSHAN HOSPITAL, GE HEALTHCARE, HEARTWARE LTD., INDRAPRASTHA APOLLO HOSPITAL, ITGI MEDICAL LTD., MEDTRONIC, INC., MERIT MEDICAL SYSTEMS, INC., MOLECULAR DEVICES, LLC, NIHON KOHDEN CORPORATION, SAHAJANAND MEDICAL TECHNOLOGIES PVT.,LTD., SORIN GROUP USA, INC., SPECTRANETICS INTERNATIONAL B.V, ST. JUDE MEDICAL, USCOME LIMITED and many more...

GEOGRAPHIC COVERAGE

The region-wise distribution consists of Emerging Markets (Brazil, Russia, India, China, South Africa & South Korea) analyzed individually.

Table of Contents

I. REPORT FOCUS

  • A. INTRODUCTION
  • CARDIOLOGY
  • KINDS OF CARDIAC CONDITIONS
  • A. BLOOD FLOW IN THE HEART
  • B. HEART MALFUNCTION
  • TYPES OF CARDIAC ARREST
  • C. MYOCARDIUM
  • DISORDERS OF MYOCARDIUM
  • D. PERICARDIUM
  • E. HEART VALVES
  • DISORDERS OF HEART VALVES
  • F. CONGENITAL HEART DEFECT
  • TYPES OF CONGENITAL HEART DEFECT
  • G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)
  • H. HEART FAILURE
  • B. CARDIOVASCULAR DEVICES
  • DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT
  • TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME
  • TOOLS DEPLOYED IN CARDIOLOGY
  • DIAGNOSTIC TESTS AND PROCEDURES
  • CONCLUSION
  • C. PERIPHERAL VASCULAR DEVICES
  • PERIPHERAL VASCULAR DISEASE (PVD)
  • AN EVALUATION OF BALLOON-EXPANDABLE-STENT IMPLANTATION WITH BALLOON ANGIOPLASTY IN PATIENTS WITH CORONARY ARTERY DISEASE
  • CARDIOVASCULAR DEATHS KEY FACTS

I. PERIPHERAL VASCULAR STENTS

  • APPROVED STENTS

II. VASCULAR CLOSURE DEVICES

  • MANUAL COMPRESSION
  • ARTERIAL CLOSURE DEVICES (ACDS):
  • PASSIVE VASCULAR CLOSURE DEVICES:
  • PASSIVE VASCULAR CLOSURE DEVICES - LIST OF DEVICES
  • ACTIVE VASCULAR CLOSURE DEVICES:
  • CONCLUSION
  • GLOBAL VASCULAR CLOSURE DEVICES MARKET WILL CONTRACT SCARCELY THROUGH 2022

III. AAA STENT GRAFTS

  • AAA PREVALENCE
  • AAA SYMPTOMS
  • AAA DIAGNOSIS
  • BENEFITS OF INTERVENTIONAL REPAIR
  • DISADVANTAGES OF INTERVENTIONAL REPAIR

IV. INFERIOR VENA CAVA (IVC) FILTERS

  • PREVALENT ISSUES RELATING TO FAILURE, TO INCLUDE DEATH (THE OTHER 4% OF CASES) INCLUDE
  • ANTICOAGULATION
  • SIDE EFFECTS
  • INFERIOR VENA CAVA FILTER PLACEMENT AND ABSTRACTION
  • RETRIEVAL
  • PERIPHERAL GUIDEWIRES

V. ATHERECTOMY DEVICES

  • THE UTILIZATION OF ATHERECTOMY AS EFFICACIOUS IN THE PERIPHERAL VESSELS IN PATIENTS WHO MEET THE FOLLOWING CRITERIA
  • COMPETITIVE CHANGES
  • MEDTRONIC LAUNCHES ASPIRATION CATHETER
  • STRATEGIES FOR OPTIMIZING ATHERECTOMY DEVICES SELECTION, TECHNIQUES
  • ATHERECTOMY: THE LITTLE DEVICES THAT COULD
  • COMPLEX DISEASE STATE

VI. CHRONIC TOTAL OCCLUSION (CTO) DEVICES

  • PERIPHERAL CTO CROSSING DEVICES
  • TRUPATH® PERIPHERAL CTO CROSSING DEVICES - FEATURES
  • VIANCE & ENTEER PERIPHERAL CTO CROSSING SOLUTIONS
  • CHRONIC TOTAL OCCLUSION ANGIOPLASTY IN THE UNITED STATES
  • BENEFITS OF CTO-PCI
  • THE BARRIERS TO PERFORMING CTO-PCI
  • CTO-PCI TECHNIQUES
  • 1. ANTEGRADE TECHNIQUES
  • 2. RETROGRADE TECHNIQUES
  • CONCLUSION

VII. THROMBECTOMY DEVICES

  • A. PERCUTANEOUS ASPIRATION THROMBECTOMY
  • B. PULLBACK THROMBECTOMY AND TRAPPING
  • MERCI RETRIEVAL SYSTEM
  • C. RECIRCULATION MECHANICAL THROMBECTOMY
  • HELIX CLOT BUSTER
  • THROMCAT THROMBECTOMY CATHETER
  • ANGIOJET
  • HYDROLYSER PERCUTANEOUS THROMBECTOMY CATHETER

D. DIRECT CONTACT MECHANICAL FRAGMENTATION

VIII. EMBOLIC PROTECTION DEVICES (EPD)

  • VARIOUS EPD TYPES ARE EXPOUNDED BELOW
  • A. BALLOON OCCLUSION DEVICES
  • B. CATHETER OCCLUSION DEVICES
  • ONE IN 4 CVADS MAY BECOME OCCLUDED
  • FIBRIN FORMATION IS A NATURAL PROCESS
  • SUMMARY
  • C. FILTER DEVICES
  • EPD PROCEDURES
  • A. CAROTID ARTERY STENTING
  • QUESTIONING THE SYSTEMS
  • B. TRANSCATHETER AORTIC VALVE (TAVR)
  • TAVR: A 10-YEAR EVOLUTION FROM CONCEPTION TO ESTABLISHED THERAPY
  • VALVE-IN-VALVE REGISTRY
  • TRANSCATHETER APPROACHES TO TREAT FAILING PROSTHETIC VALVES
  • ADVANCES IN IMAGING IN TAVR
  • ONGOING ISSUES IN TAVR
  • CONCLUSION
  • D. PERIPHERAL VASCULAR DEVICES - MARKET BRIEFING
  • CHINA
  • INDIA
  • BRAZIL
  • RUSSIA
  • SOUTH KOREA
  • SOUTH AFRICA

II. MARKET ANALYSIS

  • PERIPHERAL VASCULAR DEVICES - BRICSS - INDUSTRY SNAPSHOT
  • A. PERIPHERAL VASCULAR DEVICES - SEGMENTATION
  • PERIPHERAL VASCULAR DEVICES - GLOBAL
  • PERIPHERAL VASCULAR DEVICES - BRICSS
  • PERIPHERAL VASCULAR DEVICES - BY TYPE
  • PERIPHERAL VASCULAR DEVICES - BRICSS
  • PERIPHERAL VASCULAR STENTS
  • VASCULAR CLOSURE DEVICES (VCD)
  • AAA STENT GRAFTS
  • INFERIOR VENA CAVA (IVC) FILTERS
  • PERIPHERAL GUIDEWIRES
  • ATHERECTOMY DEVICES
  • CHRONIC TOTAL OCCLUSION (CTO) DEVICES
  • THROMBECTOMY DEVICES
  • EMBOLIC PROTECTION DEVICES (EPD)
  • B. GROWTH RATE ANALYSIS
  • BRICSS PERIPHERAL VASCULAR DEVICES - MARKET GROWTH RATES
  • PERIPHERAL VASCULAR DEVICES
  • BRICSS PERIPHERAL VASCULAR DEVICES - GROWTH RATES
  • C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

  • FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
  • AN ENCOURAGING JAB FOR TORPID PERIODS
  • A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
  • CARDIAC RHYTHM MANAGEMENT DEVICES
  • CRM IN EUROPE
  • CARDIAC DEFIBRILLATORS
  • RAPID GROWTH IN DEFIBRILLATOR SALES
  • CARDIAC PACEMAKER DEVICES
  • THE DATA COLLECTION WORK
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT)
  • CARDIAC MONITORING AND DIAGNOSTIC DEVICES
  • THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
  • INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
  • THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW
  • INTERVENTIONAL CARDIAC DEVICES
  • CORONARY STENTS
  • EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION
  • FFR IMPACT ON DES MARKET
  • MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET
  • CARDIAC CATHETERS
  • COMPETITIVE ANALYSIS
  • ELECTROPHYSIOLOGY CATHETERS (EP)
  • GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
  • DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH
  • EP MAPPING
  • NEW AF ABLATION DEVICES SEEK APPROVAL
  • ATRIAL FIBRILLATION (AF)
  • INTRAVASCULAR ULTRASOUND (IVUS)
  • GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS
  • PERIPHERAL VASCULAR DEVICES
  • ARTERIOTOMY CLOSURE DEVICES
  • EMBOLIC PROTECTION DEVICES (EPD)
  • INFERIOR VENA CAVA (IVC) FILTERS
  • CONCLUSION
  • PERIPHERAL GUIDEWIRES
  • AV ACCESS THROMBECTOMY DEVICES
  • PROSTHETIC HEART VALVES
  • SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW
  • MARKET CHALLENGES
  • B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE
  • DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
  • SIZE AND WEIGHT
  • POWER EFFICIENCY
  • PERFORMANCE SPECIFICATIONS
  • RISK MITIGATION AND RELIABILITY
  • EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES
  • C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE
  • CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
  • IMPACT OF CVD IN EUROPE
  • IMPACT ON NEW YORK STATE
  • ECONOMIC IMPACT OF CVD IN NYS
  • HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
  • IMPACT OF CVD ON ECONOMIC STABILITY
  • ECONOMIC COST OF CARDIOVASCULAR DISEASES
  • COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030
  • CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE
  • D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND
  • E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES
  • F. MARKET TRENDS
  • PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL
  • CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS
  • GE HEALTHCARE'S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
  • GE'S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
  • CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
  • INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
  • TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
  • INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
  • STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)
  • VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
  • VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
  • STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION
  • GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL
  • MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES
  • B. BRAUN'S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD
  • MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING
  • RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH
  • A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN
  • ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY
  • SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.
  • FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK'S NEW EVIA HF-T PACEMAKER.
  • AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL
  • SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS
  • USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS
  • MORTARA INSTRUMENT, INC. LAUNCHES “BUILT WITH PRIDE IN MILWAUKEE” CAMPAIGN.
  • MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT
  • DRUG-ELUTING STENTS ARE SECURE
  • CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE'S USER SATISFACTION SURVEY
  • ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME
  • ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT
  • ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.
  • BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENT™ SOLUTIONS.
  • HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS
  • FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK
  • FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE “MOST ADMIRED COMPANY”
  • BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE
  • COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET
  • MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE
  • MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.
  • NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY-INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH
  • FIRST IMPLANT OF BOSTON SCIENTIFIC'S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA
  • STUDY REVEALS THAT BAYER HEALTHCARE'S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.
  • USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS
  • SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011
  • TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY
  • CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL
  • SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)
  • EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.
  • ZOLL NOMINATED TO GLOBE 100 AGAIN
  • USCOM ENTERS EUROPEAN MARKETS
  • POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS
  • USCOM SECURES STRONG PRESENCE IN US AND CANADA
  • CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES
  • COVIDIEN INTRODUCES NEW GLOBAL PACKAGING
  • STENTYS'S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.
  • SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT
  • CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD
  • USCOM EYES EASTERN EUROPEAN MARKET
  • VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART
  • INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES
  • INFECTIONS FROM IMPLANTED CARDIAC DEVICES
  • TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION
  • HEART TRANSPLANTS SUBSTITUTED BY A PUMP
  • DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)
  • REMOTE MONITORING OF HEART FAILURE PATIENTS
  • EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES
  • OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION
  • IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH
  • OVER-THE-COUNTER APPARATUS
  • BOSTON SCIENTIFICS' IMPLANTABLE DEFIBRILLATOR
  • CARDIAC SCIENCE'S NEW CARDIAC TREATMENT
  • THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION
  • CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD
  • LOCAL MEDICARE'S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY
  • A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION
  • A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC
  • LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA
  • INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS
  • BEST AND LATEST SELF-TEACHING HEART SOUNDS
  • REPLACING VALVE WITHOUT CARDIAC SUPPORT
  • U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT
  • AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES
  • NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA
  • MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS
  • G. KEY COMPANY PROFILES
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD
  • OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES
  • CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
  • CARDIAC MEDICAL DEVICES - PATENTS
  • KEY COMPANIES FINANCIAL OVERVIEW

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX

  • RESEARCH FOCUS
  • ABOUT AXIS RESEARCH MIND
  • DISCLAIMER
  • FEEDBACK

LIST OF TABLES/CHARTS

I. REPORT FOCUS

  • 1. LIST OF DEVICES & ITS MANUFACTURE WITH THE DEVICE SUCCESS RATE
  • 2. UNADJUSTED RATES OF IN-HOSPITAL ADVERSE EVENTS BY CAROTID STENTING SYSTEM
  • 3. ADJUSTED RISK OF THE PRIMARY OUTCOME BETWEEN SYSTEMS
  • 4. LIST OF NEXT GENERATION TAVR SYSTEMS OF KEY MANUFACTURES
  • D. PERIPHERAL VASCULAR DEVICES - MARKET BRIEFING

CHINA

  • 5. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) FOR CHINA - (2012-2018, IN USD$ THOUSAND)
  • 6. PERIPHERAL VASCULAR DEVICES - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) - % OF CHINESE MARKET VALUE - (2015 - 2018)

INDIA

  • 7. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) FOR INDIA - (2012-2018, IN USD$ THOUSAND)
  • 8. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) - % OF INDIAN MARKET VALUE - (2015 - 2018)

BRAZIL

  • 9. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) FOR BRAZIL - (2012-2018, IN USD$ THOUSAND)
  • 10. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) - % OF BRAZILIAN MARKET VALUE - (2015 - 2018)

RUSSIA

  • 11. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) FOR RUSSIA - (2012-2018, IN USD$ THOUSAND)
  • 12. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) - % OF RUSSIA MARKET VALUE - (2015 - 2018)

SOUTH KOREA

  • 13. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) FOR SOUTH KOREA - (2012-2018, IN USD$ THOUSAND)
  • 14. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) - % OF SOUTH KOREAN MARKET VALUE - (2015 - 2018)

SOUTH AFRICA

  • 15. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) FOR SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 16. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) - % OF SOUTH AFRICAN MARKET VALUE - (2015 - 2018)
  • E. INFERIOR VENA CAVA (IVC) FILTERS - TYPES - MARKET BRIEFING

CHINA

  • 17. INFERIOR VENA CAVA (IVC) FILTERS MARKET - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS FOR CHINA - (2012-2018, IN USD$ THOUSAND)
  • 18. INFERIOR VENA CAVA (IVC) FILTERS - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS - % OF CHINESE MARKET VALUE - (2015 - 2018)

INDIA

  • 19. INFERIOR VENA CAVA (IVC) FILTERS MARKET - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS FOR INDIA - (2012-2018, IN USD$ THOUSAND)
  • 20. INFERIOR VENA CAVA (IVC) FILTERS MARKET - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS - % OF INDIAN MARKET VALUE - (2015 - 2018)

BRAZIL

  • 21. INFERIOR VENA CAVA (IVC) FILTERS MARKET - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS FOR BRAZIL - (2012-2018, IN USD$ THOUSAND)
  • 22. INFERIOR VENA CAVA (IVC) FILTERS - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS - % OF BRAZIL MARKET VALUE - (2015 - 2018)

RUSSIA

  • 23. INFERIOR VENA CAVA (IVC) FILTERS MARKET - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS FOR RUSSIA - (2012-2018, IN USD$ THOUSAND)
  • 24. INFERIOR VENA CAVA (IVC) FILTERS - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS - % OF RUSSIAN MARKET VALUE - (2015 - 2018)

SOUTH KOREA

  • 25. INFERIOR VENA CAVA (IVC) FILTERS MARKET - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS FOR SOUTH KOREA - (2012-2018, IN USD$ THOUSAND)
  • 26. INFERIOR VENA CAVA (IVC) FILTERS - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS - % OF SOUTH KOREAN MARKET VALUE - (2015 - 2018)

SOUTH AFRICA

  • 27. INFERIOR VENA CAVA (IVC) FILTERS MARKET - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS FOR SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 28. INFERIOR VENA CAVA (IVC) FILTERS MARKET - TYPES - RETRIEVABLE FILTERS AND PERMANENT IVC FILTERS - % OF SOUTH AFRICAN MARKET VALUE - (2015 - 2018)
  • 29. PERIPHERAL VASCULAR DEVICES - PRODUCT BY BRANDS

II. MARKET ANALYSIS

  • 30. BRICSS PERIPHERAL VASCULAR DEVICES - SEGMENTATION BY TYPES
  • PERIPHERAL VASCULAR DEVICES - GLOBAL
  • 31. PERIPHERAL VASCULAR DEVICES MARKET - GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ THOUSAND)
  • PERIPHERAL VASCULAR DEVICES - BRICSS
  • 32. PERIPHERAL VASCULAR DEVICES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ THOUSAND)
  • 33. PERIPHERAL VASCULAR DEVICES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 34. PERIPHERAL VASCULAR DEVICES MARKET - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • PERIPHERAL VASCULAR DEVICES - BY TYPE
  • 35. PERIPHERAL VASCULAR DEVICES MARKET - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) FOR BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ THOUSAND)
  • 36. PERIPHERAL VASCULAR DEVICES - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES (VCD), AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) - % OF BRICSS MARKET VALUE - (2015-2018)
  • PERIPHERAL VASCULAR DEVICES - BRICSS
  • PERIPHERAL VASCULAR STENTS
  • 37. PERIPHERAL VASCULAR STENTS MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 38. PERIPHERAL VASCULAR STENTS - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • VASCULAR CLOSURE DEVICES (VCD)
  • 39. VASCULAR CLOSURE DEVICES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 40. VASCULAR CLOSURE DEVICES - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • AAA STENT GRAFTS
  • 41. AAA STENT GRAFTS MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 42. AAA STENT GRAFTS - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • INFERIOR VENA CAVA (IVC) FILTERS
  • 43. INFERIOR VENA CAVA (IVC) FILTERS MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 44. INFERIOR VENA CAVA (IVC) FILTERS - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • PERIPHERAL GUIDEWIRES
  • 45. PERIPHERAL GUIDEWIRES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 46. PERIPHERAL GUIDEWIRES - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • ATHERECTOMY DEVICES
  • 47. ATHERECTOMY DEVICES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 48. ATHERECTOMY DEVICES - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • CHRONIC TOTAL OCCLUSION (CTO) DEVICES
  • 49. CHRONIC TOTAL OCCLUSION (CTO) DEVICES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 50. CHRONIC TOTAL OCCLUSION (CTO) DEVICES - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • THROMBECTOMY DEVICES
  • 51. THROMBECTOMY DEVICES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 52. THROMBECTOMY DEVICES - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • EMBOLIC PROTECTION DEVICES (EPD)
  • 53. EMBOLIC PROTECTION DEVICES (EPD) MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ THOUSAND)
  • 54. EMBOLIC PROTECTION DEVICES (EPD) - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • B. GROWTH RATE ANALYSIS
  • BRICSS PERIPHERAL VASCULAR DEVICES - MARKET GROWTH RATES
  • 55. PERIPHERAL VASCULAR DEVICES MARKET - BRICSS- % GROWTH RATE FORECASTS - (2012-2018)
  • PERIPHERAL VASCULAR DEVICES
  • BRICSS PERIPHERAL VASCULAR DEVICES - GROWTH RATES
  • 56.PERIPHERAL VASCULAR DEVICES - % GROWTH RATE FORECASTS FOR PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES, AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) - (2012-2018)
  • C. INVESTMENT FOCUS
  • 57. PERIPHERAL VASCULAR DEVICES - FORECASTED CAGR% - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
  • 58. PERIPHERAL VASCULAR DEVICES - PERIPHERAL VASCULAR STENTS, VASCULAR CLOSURE DEVICES, AAA STENT GRAFTS, INFERIOR VENA CAVA (IVC) FILTERS, PERIPHERAL GUIDEWIRES, ATHERECTOMY DEVICES, CHRONIC TOTAL OCCLUSION (CTO) DEVICES, THROMBECTOMY DEVICES AND EMBOLIC PROTECTION DEVICES (EPD) - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL

III. INDUSTRY OVERVIEW

  • 59: INTRAVENOUS DIAGNOSTICS - BY TYPE - FFR - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 60: INTRAVENOUS DIAGNOSTICS - BY TYPE - OCT - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 61. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2010, IN USD BILLION)
  • 62. PROJECTED TOTAL COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2015-2030, IN USD BILLION)
  • 63. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASE BY AGE - (2012, IN USD BILLION)
  • 64. PROJECTIONS OF CRUDE CARDIOVASCULAR DISEASE PREVALENCE - (% - 2010-2030) IN THE UNITED STATES
  • 65. PROJECTED DIRECT MEDICAL COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
  • 66. PROJECTED INDIRECT LOST PRODUCTIVITY COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
  • 67. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2014
  • 68. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2013
  • 69. WORLDWIDE KEY PLAYERS INTO CARDIOVASCULAR DEVICES INDUSTRY THAT PROJECT IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE
  • 70. COVERAGE OF CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
  • 71. CARDIAC ARRHYTHMIAS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
  • 72. CIRCADIAN RHYTHM SLEEP DISORDERS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME - 2014
  • 73. PERIPHERAL VASCULAR DISEASE (PVD) DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
  • 74. ANNUAL SALES OF CARDIAC THERAPY PRODUCTS MARKETED BY THERAPY AREA - (2010-2012, IN US$ MILLION)
  • 75. ABIOMED, INC. - PRODUCT REVENUE, FOR 2011-2013 (IN US$ '000)
  • 76. ACCELLENT, INC. - NET REVENUE, FOR 2011 AND 2012 (IN US$ '000)
  • 77. ALERE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
  • 78. AMBU A/S, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN DKK MILLION)
  • 79. ANGIODYNAMICS, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ '000)
  • 80. ATRICURE, INC. - NET SALES BY PRODUCT IN DOMESTIC & INTERNATIONAL AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)
  • 81. BAXTER INTERNATIONAL, INC. - NET SALES BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ MILLION)
  • 82. BECTON, DICKINSON & CO - NET SALES BY MARKET SEGMENT, FOR 2011-2013 (IN USD$ MILLION)
  • 83. BIOHEART, INC. - NET SALES, FOR 2011-2013 (IN US$ '000)
  • 84.: BIOSENSORS INTERNATIONAL GROUP, LTD. - NET SALES REVENUE BY MARKET SEGMENT, LICENSING AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)
  • 85. BIOTELEMETRY, INC. - NET SALES REVENUE AND GROSS PROFIT, FOR 2011-2013 (IN US$ '000)
  • 86. BOSTON SCIENTIFIC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN USD$ MILLION)
  • 87. C. R. BARD, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 88. CARDICA, INC. - NET REVENUE, FOR 2011-2013 (IN US$ '000)
  • 89. COMPUMED. INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 IN USD
  • 90. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT & GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 91. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT, FOR USA AND NON-USA FOR 2011-2013 (IN US$ MILLION)
  • 92. CONMED CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 93. CRYOLIFE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 94. CRYOLIFE, INC. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 95. DELTEX MEDICAL GROUP PLC - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
  • 96. DIGIRAD CORPORATION - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 97. DRÄGER MEDICAL AG & CO. KG - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 (IN US$ 'MILLION)
  • 98. EDWARDS LIFESCIENCES LLC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ 'MILLION)
  • 99. ENDOLOGIX, INC, - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 100. HEARTWARE, LTD. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 101. HOSPIRA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 102. INDRAPRASTHA APOLLO HOSPITAL - NET REVENUE, FOR 2012-2013 (IN INDIAN RUPEES)
  • 103. INSPIREMD, LTD. - NET REVENUE, FOR 2012-2013 (IN US$ '000)
  • 104. JOHNSON & JOHNSON - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 105. KONINKLIJKE DSM N.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 IN (EURO MILLION)
  • 106. LOMBARD MEDICAL TECHNOLOGIES PLC - NET REVENUE, FOR 2011-2013 (IN US$ '000)
  • 107. OPTO CIRCUITS (INDIA) LIMITED - NET REVENUE BY CONSOLIDATED AND STANDALONE, FOR 2011-2013 (IN INDIAN RUPEES)
  • 108. MICROPORT MEDICAL (SHANGHAI) CO. LTD - NET REVENUE, FOR 2012 AND 2013 SIX MONTHS ENDED 30TH JUNE (IN RMB'000)
  • 109. ST. JUDE MEDICAL, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (US$ IN MILLION)
  • 110. TTK - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN INDIAN RUPEES)
  • 111. CARDIUM THERAPEUTICS, INC. - NET REVENUE, FOR 2012-2013 ENDED FOR NINE MONTHS (IN US$ MILLION)
  • 112. MERIT MEDICAL SYSTEMS, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 113. SPECTRANETICS INTERNATIONAL B.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 114. VARIAN MEDICAL - NET REVENUE BY MARKET AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 115. TELEFLEX MEDICAL - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 116. ABBOTT VASCULAR DEVICES - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 117. MEDTRONIC, INC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2012 (IN US$ MILLION)
  • 118. AORTECH INTERNATIONAL PLC - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 119. VOLCANO CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 120. PHILIPS MEDICAL SYSTEMS - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 121. ATCOR MEDICAL HOLDINGS LIMITED - NET REVENUE BY GEOAGRAPHY, FOR 2012 AND 2013 (IN US$ MILLION)
  • 122. LIDCO GROUP PLC - NET REVENUE BY PRODUCTS AND GEOGRAPHY, FOR 2011-2013 (IN GBP£ '000)
  • 123. SORIN GROUP USA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, 2011-2013 (IN EURO MILLION)
  • 124. THORATEC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 125. STEREOTAXIS, INC. - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2011 & 2012 (IN USD)
  • 126. F.HOFFMANN-LA ROCHE LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN CHF MILLION)
  • 127. PULSION MEDICAL SYSTEMS SE - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2012-2013 (IN EURO '000)
  • 128. NOVADAQ TECHNOLOGIES INC - NET REVENUE BY CATEGORY AND GEOGRAPHY, FOR 2011-2013 (IN USD)
  • 129. SIEMENS MEDICAL SOLUTIONS USA, INC. - NET REVENUE BY GEOGRAPHY AND MARKET SEGMENT, FOR 2012 AND 2013 (IN € MILLION)
  • 130. FUKUDA DENSHI CO. LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN MILLION YEN)
  • 131. NIHON KOHDEN CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN MILLION YEN)
  • 132. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 AND 2012 (IN YUAN)
  • 133. ASAHI KASEI CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN ‘¥' YEN)

KEY COMPANY PROFILES

NORTH AMERICA

  • ALERE, INC.
  • CARDIOROBOTICS, INC.
  • INTERFACE BIOLOGICS, INC.
  • MERIDIAN HEALTH SYSTEM, INC
  • CARDIVA MEDICAL, INC.
  • LOMBARD MEDICAL TECHNOLOGIES PLC
  • DELTEX MEDICAL GROUP PLC
  • BIOTELEMETRY, INC.
  • BIOHEART, INC.
  • ASAHI INTECC CO., LTD.
  • ANGIODYNAMICS, INC.
  • MERIT MEDICAL SYSTEMS, INC.
  • MOLECULAR DEVICES, LLC
  • ACCELLENT, INC.
  • MEDTRONIC, INC.
  • ABBOTT VASCULAR DEVICES
  • CAMBRIDGE HEART, INC.
  • GREATBATCH, INC.
  • ABIOMED, INC.
  • ADVANSOURCE BIOMATERIALS CORPORATION
  • ATRICURE, INC.
  • ATRIUM MEDICAL CORPORATION
  • BIOPHAN TECHNOLOGIES, INC.
  • BIOSENSE WEBSTER, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • CARDIAC SCIENCE CORPORATION
  • CARDIACASSIST, INC.
  • CARDICA, INC.
  • COOK GROUP INCORPORATED
  • CORDIS CORPORATION
  • CRYOLIFE INC.
  • MAQUET GMBH & CO. KG
  • DIGIRAD CORPORATION
  • EDWARDS LIFESCIENCES, LLC.
  • ENDOLOGIX INCORPORATED
  • ISSYS SENSING SYSTEMS, INC
  • APTUS ENDOSYSTEMS, INC.
  • FLUXION
  • JOHNSON & JOHNSON
  • KONINKLIJKEDSM N.V.
  • MEDRAD, INC.
  • BIOCLINICA
  • MILLAR INSTRUMENTS, INC
  • MONEBO TECHNOLOGIES, INC.
  • MORTARA INSTRUMENT, INC.
  • SIEMENS MEDICAL SOLUTIONS USA, INC.
  • SONOSITE, INC.
  • SORIN GROUP USA, INC.
  • ST. JUDE MEDICAL
  • STEREOTAXIS, INC.
  • TELEFLEX, INC.
  • CARDIOVASCULARSYSTEMS, INC.
  • TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
  • TERUMO HEART, INC.
  • THORATEC CORPORATION
  • VICOR TECHNOLOGIES, INC.
  • VOLCANO CORPORATION
  • COMPUMED, INC.
  • PULSION MEDICAL SYSTEMS SE
  • 3M HEALTHCARE
  • BAXTER INTERNATIONAL INC.
  • BECTON, DICKINSON & CO.
  • NOVADAQ TECHNOLOGIES INC.
  • SCOTTCARE CARDIOVASCULAR SOLUTIONS
  • VARIAN MEDICAL SYSTEMS, INC.
  • THERMEDICS, INC.
  • LEVITRONIX, LLC
  • SUNSHINE HEART, INC.
  • ACCUTECH, LLC
  • ASH ACCESS TECHNOLOGY, INC.
  • C. R. BARD, INC.
  • CONMED CORPORATION
  • HOSPIRA, INC.
  • SURGICAL SPECIALISTIES CORPORATION
  • CARDIUM THERAPEUTICS, INC.
  • CIRCULITE, INC.
  • CARDIOCOMM SOLUTIONS, INC.

EUROPE

  • BERLIN HEART GMBH
  • ESAOTE S.P.A
  • SOPHION BIOSCIENCE A/S
  • BIOTRONIK GMBH & CO. KG.
  • DRÄGER MEDICAL AG & CO. KG
  • BIOTEQUE CORPORATION
  • SPECTRANETICS INTERNATIONAL B.V
  • AORTECH INTERNATIONAL, PLC.
  • APC CARDIOVASCULAR, LTD.
  • ARTERIAL REMODELING TECHNOLOGIES
  • GE HEALTHCARE
  • LIDCO GROUP PLC
  • PHILIPS MEDICAL SYSTEMS
  • SMITH & NEPHEW PLC
  • VASCULAR CONCEPTS
  • AMBU A/S
  • FLEMING MEDICAL LIMITED
  • COVIDIEN PLC

ASIA-PACIFIC

  • NIHON KOHDEN CORPORATION
  • ALL PRO CORPORATION
  • FUKUDA DENSHI CO., LTD.
  • SICHUAN JINJIANG ELECTRONIC SCIENCE AND TECHNOLOGY CO., LTD
  • SYNCARDIA SYSTEMS, INC.
  • MICROPORTS MEDICAL
  • LEPU MEDICAL
  • BEIJING ANZHEN HOSPITAL
  • FUDAN UNIVERSITY ZHONGSHAN HOSPITAL
  • INDRAPRASTHA APOLLO HOSPITAL
  • SAHAJANAND MEDICAL TECHNOLOGIES PVT.,LTD.
  • OPTO CIRCUITS INDIA LIMITED
  • ASAHI KASEI CORPORATION
  • ASIAN HEART INSTITUTE
  • NARAYANA HRUDAYALAYA
  • USCOME LIMITED
  • HEARTWARE LTD.
  • BIOSENSORS INTERNATIONAL GROUP, LTD.
  • ATCOR MEDICAL HOLDINGS LIMITED
  • CATHRX LTD
  • TTK HEALTHCARE
  • GOODMAN CO., LTD.

REST OF WORLD

  • INSPIREMD LTD.
  • ITGI MEDICAL LTD.
  • MEDINOL, LTD.
  • GAMIDA CELL LTD.
  • AEROTEL MEDICAL SYSTEMS, LTD.
Back to Top